Factors associated with intravenous lidocaine in pediatric patients undergoing laparoscopic appendectomy - a

Christian P Both1, Jörg Thomas1, Philipp K Bühler1

  • 1Department of Anesthesia, University Children's Hospital, Steinwiesstrasse 75, CH-8032, Zurich, Switzerland.

BMC Anesthesiology
|July 20, 2018
PubMed

Insights

Intravenous lidocaine was safely administered to pediatric patients undergoing laparoscopic appendectomy. This study found no adverse effects, supporting its use in children for this procedure.

Area of Science:

  • Anesthesiology
  • Pediatric Surgery
  • Pharmacology

Background:

  • Intravenous lidocaine is increasingly used perioperatively for its beneficial effects in adults undergoing surgery.
  • Its use in pediatric laparoscopic procedures, like appendectomy, is less studied.
  • Lidocaine was integrated into standard care for pediatric laparoscopic surgeries at University Children's Hospital Zurich in mid-2016.

Purpose of the Study:

  • To evaluate the safety and potential adverse effects of perioperative intravenous lidocaine in children undergoing laparoscopic appendectomy.
  • To compare outcomes between pediatric patients receiving lidocaine and those who did not.

Main Methods:

  • Retrospective analysis of 116 pediatric patients undergoing laparoscopic appendectomy in 2016.
  • Comparison of patients who received intravenous lidocaine (post-07/01/2016) versus those who did not (pre-07/01/2016).
  • Evaluation for systemic toxicity, neurological/cardiovascular effects, behavioral changes, hemodynamic instability, and postoperative outcomes (nausea, vomiting, pain, discharge time, bowel movement, complications).

Main Results:

  • Data from 116 patients analyzed; 60 received lidocaine.
  • No instances of systemic lidocaine toxicity, neurological impairment, or circulatory disturbances were observed.
  • A non-significant trend towards less emergence delirium in the lidocaine group (0 cases vs. 4 cases, p=0.05).

Conclusions:

  • Perioperative intravenous lidocaine administration appears safe in pediatric patients undergoing laparoscopic appendectomy under general anesthesia.
  • No adverse effects were identified in this retrospective analysis.
  • Further research is needed to explore the beneficial effects and pharmacokinetics of intravenous lidocaine in pediatric populations.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
317
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
237
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
327
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
305
What is an Experiment?01:12

What is an Experiment?

An experiment is a planned activity carried out under controlled conditions. The purpose of an experiment is to investigate the relationship between two variables. When one variable causes change in another, we call the first variable the explanatory or independent variable. The affected variable is called the response or dependent variable. In a randomized experiment, the researcher manipulates values of the explanatory variable and measures the resulting changes in the response variable. The...
18.9K